BOSTON SCIENTIFIC CORPORATION (BSX) Operating Margin
- Operating margin · 12 months: Value 19.78%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 19.78% | Operating income / revenue. Period ending 2026-06-30. $4.15B ÷ $21.00B × 100 ≈ 19.78% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 4.15B USD | Operating Income (Loss) |
| Revenue | 21.00B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 6.32B USD | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | 7.16B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4.15B | $21.00B | $6.32B | (m) | $7.16B | 19.78% |
| 2026-03-31 | $3.79B | $20.61B | $6.36B | (m) | $7.07B | 18.40% |
| 2025-12-31 | $3.61B | $20.07B | $6.22B | (m) | $6.89B | 18.00% |
| 2025-09-30 | $3.46B | $19.35B | $6.08B | (m) | $6.67B | 17.90% |
| 2025-06-30 | $3.15B | $18.49B | $5.87B | (m) | $6.49B | 17.02% |
| 2025-03-31 | $2.85B | $17.55B | $5.50B | (m) | $6.22B | 16.23% |
| 2024-12-31 | $2.60B | $16.75B | $5.26B | (m) | $5.98B | 15.54% |
| 2024-09-30 | $2.51B | $15.91B | $4.94B | (m) | $5.75B | 15.79% |
| 2024-06-30 | $2.47B | $15.23B | $4.73B | (m) | $5.43B | 16.23% |
| 2024-03-31 | $2.47B | $14.71B | $4.51B | (m) | $5.34B | 16.77% |
| 2023-12-31 | $2.34B | $14.24B | $4.34B | (m) | $5.19B | 16.45% |
| 2023-09-30 | $2.16B | $13.76B | $4.21B | (m) | $4.97B | 15.71% |
| 2023-06-30 | $1.83B | $13.40B | $4.09B | (m) | $4.87B | 13.63% |
| 2023-03-31 | $1.74B | $13.04B | $4.04B | (m) | $4.67B | 13.30% |
| 2022-12-31 | $1.65B | $12.68B | $3.96B | (m) | $4.52B | 13.00% |
| 2022-09-30 | $1.43B | $12.57B | $3.92B | (m) | $4.51B | 11.36% |
| 2022-06-30 | $1.46B | $12.33B | $3.84B | (m) | $4.45B | 11.81% |
| 2022-03-31 | $1.29B | $12.16B | $3.77B | (m) | $4.40B | 10.65% |
| 2021-12-31 | $1.20B | $11.89B | $3.71B | (m) | $4.36B | 10.09% |
| 2021-09-30 | $1.07B | $11.47B | $3.74B | (m) | $4.23B | 9.32% |
| 2021-06-30 | $477.00M | $11.20B | $3.71B | (m) | $4.15B | 4.26% |
| 2021-03-31 | $144.00M | $10.12B | $3.55B | (m) | $3.83B | 1.42% |
| 2020-12-31 | $-80.00M | $9.91B | $3.46B | (m) | $3.79B | -0.81% |
| 2020-09-30 | $80.00M | $10.11B | $3.32B | (m) | $3.85B | 0.79% |
| 2020-06-30 | $668.00M | $10.16B | $3.22B | (m) | $3.88B | 6.58% |
| 2020-03-31 | $1.12B | $10.79B | $3.19B | (m) | $4.05B | 10.41% |
| 2019-12-31 | $1.52B | $10.73B | $3.12B | (m) | $3.94B | 14.14% |
| 2019-09-30 | $1.63B | $10.39B | $2.99B | (m) | $3.80B | 15.66% |
| 2019-06-30 | $1.63B | $10.08B | $2.89B | (m) | $3.66B | 16.20% |
| 2019-03-31 | $1.64B | $9.94B | $2.87B | (m) | $3.58B | 16.50% |
| 2018-12-31 | $1.51B | $9.82B | $2.81B | (m) | $3.57B | 15.33% |
| 2018-09-30 | $1.50B | $9.67B | $2.76B | (m) | $3.50B | 15.56% |
| 2018-06-30 | $1.50B | $9.50B | $2.72B | (m) | $3.43B | 15.74% |
| 2018-03-31 | $1.33B | (m) | $2.62B | (m) | $3.36B | (m) |
| 2017-12-31 | $1.28B | $9.05B | $2.59B | (m) | $3.29B | 14.20% |
| 2017-09-30 | $1.11B | (m) | $2.54B | (m) | $3.24B | (m) |
| 2017-06-30 | $1.08B | (m) | $2.50B | (m) | $3.21B | (m) |
| 2017-03-31 | $518.00M | (m) | $2.50B | (m) | $3.18B | (m) |
| 2016-12-31 | $447.00M | (m) | $2.42B | (m) | $3.10B | (m) |
| 2016-09-30 | $36.00M | (m) | $2.38B | (m) | $3.05B | (m) |
| 2016-06-30 | $-611.00M | (m) | $2.32B | (m) | $3.00B | (m) |
| 2016-03-31 | $-58.00M | (m) | $2.23B | (m) | $2.92B | (m) |
| 2015-12-31 | $-327.00M | (m) | $2.17B | (m) | $2.87B | (m) |
| 2015-09-30 | $-548.00M | (m) | $2.16B | (m) | $2.85B | (m) |
| 2015-06-30 | $-186.00M | (m) | $2.17B | (m) | $2.86B | (m) |
| 2015-03-31 | $-474.00M | (m) | $2.19B | (m) | $2.90B | (m) |
| 2014-12-31 | $-301.00M | (m) | $2.21B | (m) | $2.90B | (m) |
| 2014-09-30 | $317.00M | (m) | $2.21B | (m) | $2.87B | (m) |
| 2014-06-30 | $357.00M | (m) | $2.17B | (m) | $2.79B | (m) |
| 2014-03-31 | $647.00M | (m) | $2.13B | (m) | $2.71B | (m) |
| 2013-12-31 | $120.00M | $7.14B | $2.17B | (m) | $2.67B | 1.68% |
| 2013-09-30 | $111.00M | $7.13B | $2.20B | (m) | $2.59B | 1.56% |
| 2013-06-30 | $-587.00M | $7.13B | $2.25B | (m) | $2.52B | -8.24% |
| 2013-03-31 | $-4.39B | $7.14B | $2.30B | (m) | $2.51B | -61.51% |
| 2012-12-31 | $-3.87B | $7.25B | $2.35B | (m) | $2.54B | -53.36% |
| 2012-09-30 | $-3.81B | $7.28B | $2.43B | (m) | $2.52B | -52.43% |
| 2012-06-30 | $-3.05B | $7.42B | $2.55B | (m) | $2.56B | -41.07% |
| 2012-03-31 | $778.00M | $7.56B | $2.66B | (m) | $2.55B | 10.29% |
| 2011-12-31 | $904.00M | $7.62B | $2.66B | (m) | $2.49B | 11.86% |
| 2011-09-30 | $1.08B | $7.78B | $2.66B | (m) | $2.55B | 13.91% |
| 2011-06-30 | $1.16B | $7.82B | $2.60B | (m) | $2.56B | 14.82% |
| 2011-03-31 | $1.15B | $7.77B | $2.57B | (m) | $2.55B | 14.82% |
| 2010-12-31 | $-656.00M | $7.81B | $2.60B | (m) | $2.58B | -8.40% |
| 2010-09-30 | $-2.23B | $7.88B | $2.65B | (m) | $2.54B | -28.35% |
| 2010-06-30 | $-2.44B | $7.99B | $2.65B | (m) | $2.58B | -30.48% |
| 2010-03-31 | $-2.39B | $8.14B | $2.63B | (m) | $2.61B | -29.38% |
| 2009-12-31 | $-894.00M | $8.19B | $2.58B | (m) | $2.63B | -10.92% |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $-1.50B | $8.05B | $2.47B | (m) | $2.59B | -18.70% |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | $-14.00M | $8.36B | $2.34B | (m) | $2.91B | -0.17% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |